Why Perspective Therapeutics (CATX) Shares Are Falling

Perspective Therapeutics Inc CATX shares are trading lower by 12.9% to $0.38 Thursday morning after the company announced the pricing of an underwritten public offering.

The offering includes 132,075,218 shares of common stock at $0.37 per share and pre-funded warrants for 30,086,944 shares at $0.369 per warrant. The total gross proceeds are estimated to be around $60 million.

Oppenheimer & Co. and B. Riley Securities are serving as joint book-running managers, and there is an option for underwriters to purchase up to an additional 24,324,324 shares within 30 days.

See Also: Healthcare Insurance Giant Humana Stock Hits 52-Week Low

According to data from Benzinga Pro, CATX has a 52-week high of $0.73 and a 52-week low of $0.20.